CpG ODN G9.1 as a novel nasal ODN adjuvant elicits complete protection from influenza virus infection without causing inflammatory immune responses

Authors:

Abstract
No abstract available
Funding Information
  • Japan Agency for Medical Research and Development

This publication has 40 references indexed in Scilit: